Novo Nordisk A/S has announced the launch of its acclaimed obesity drug, Wegovy, in China, a strategic move aimed at tapping into the world’s second-largest economy’s burgeoning weight-loss market. The drug, known for its impact on body weight management, will be available at a remarkably lower price compared to its cost in the United States, […]
Wellness Wants In on the Ozempiconomy
In recent months, a remarkable trend has emerged within the wellness sector, closely following the pharmaceutical industry’s innovations. The spotlight is on GLP-1 receptor agonists, hormones that have gained notoriety due to their association with popular weight loss drugs like Ozempic and Wegovy. As wellness brands jostle to stake their claim in this burgeoning field, […]